Avery Dennison

AVYNYSEUSD

THESIS ALERT

Email me when the AVY thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$188.18
−$0.86 (−0.45%)Today 1M +12.13%
After hours$188.180.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$189.04
Prior regular-session close from the quote source.
$186.47–$188.92
Regular-session low and high so far today.
375.7K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 3 projected
Projected for 2027-02-03 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$152.42–$199.54
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own AVY if its label-and-identification consumables franchise can keep pricing above input-cost cycles while newer higher-value identification use cases add growth faster than the mature materials base fades.

AVY price history

Latest price$188.18Today−$0.86 (-0.45%)
AVY +11.77%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Avery Dennison’s customer-specific labeling and converted-materials products remain embedded enough in customer operations that reorder demand normalizes after inventory cycles rather than permanently migrating to substitutes or cheaper competitors.HoldingMateriality: High

    GAAP annual revenue recovered from $8.36 billion in FY2023 to $8.76 billion in FY2024 and $8.86 billion in FY2025. If this holds, revenue can compound from recurring usage; if it breaks, the company becomes a lower-growth commodity converter with weaker pricing.

    Watch: Large consumer-packaged-goods or retail customers redesign packaging workflows around direct printing, linerless formats, or lower-label-content solutions.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue recovered from $8.36 billion in FY2023 to $8.76 billion in FY2024 and $8.86 billion in FY2025.

    Open source ↗
  • Avery Dennison’s coatings, adhesives, converting scale, and customer qualification requirements allow it to protect price/cost spread through raw-material cycles rather than passing all value to customers.StrengtheningMateriality: High

    GAAP annual gross profit increased from $2.28 billion in FY2023 to $2.53 billion in FY2024 and $2.55 billion in FY2025. This is the difference between a specialty materials business and a commodity converter; it drives margin resilience and valuation quality.

    Watch: Raw paper, film, resin, chemical, or freight inflation accelerates faster than Avery Dennison can reprice contracts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit increased from $2.28 billion in FY2023 to $2.53 billion in FY2024 and $2.55 billion in FY2025.

    Open source ↗
  • The consumables nature of Avery Dennison’s business and its operating discipline continue to convert accounting earnings into cash that can fund reinvestment, acquisitions, dividends, and repurchases without starving the franchise.StrengtheningMateriality: Medium

    GAAP annual operating cash flow was $826.0 million in FY2023, $938.8 million in FY2024, and $881.4 million in FY2025. Durable cash conversion lets owners benefit even in a low-growth end market; weak conversion would make growth and capital returns less valuable.

    Watch: Customer destocking or supplier terms reversal causes a sustained working-capital drag.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was $826.0 million in FY2023, $938.8 million in FY2024, and $881.4 million in FY2025.

    Open source ↗
  • Per-share value creation depends on Avery Dennison pairing capital returns with actual operating improvement; buybacks alone cannot offset a stagnant profit pool for long.HoldingMateriality: Medium

    GAAP diluted EPS rose from $6.20 in FY2023 to $8.73 in FY2024 and $8.79 in FY2025. If EPS growth is mostly financial engineering, owners face multiple compression when repurchase capacity or earnings quality is questioned.

    Watch: Management prioritizes repurchases while operating income or net income stagnates.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP diluted EPS rose from $6.20 in FY2023 to $8.73 in FY2024 and $8.79 in FY2025.

    Open source ↗
  • Avery Dennison must keep balance-sheet leverage from becoming the hidden cost of acquisitions and capital returns, because the thesis relies on flexibility through industrial cycles.WeakeningMateriality: Medium

    GAAP liabilities were $6.56 billion at FY2025 versus $6.09 billion at FY2024, showing leverage-related claims on the business increased. If liabilities keep rising faster than cash generation, the company loses room to invest through downturns and the equity deserves a lower multiple.

    Watch: Debt-funded acquisitions or repurchases continue while organic growth remains muted.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP liabilities were $6.56 billion at FY2025 versus $6.09 billion at FY2024, showing leverage-related claims on the business increased.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Avery Dennison’s customer-specific labeling and converted-materials products remain embedded enough in customer operations that reorder demand normalizes after inventory cycles rather than permanently migrating to substitutes or cheaper competitors. If this holds, revenue can compound from recurring usage; if it breaks, the company becomes a lower-growth commodity converter with weaker pricing.

Avery Dennison’s coatings, adhesives, converting scale, and customer qualification requirements allow it to protect price/cost spread through raw-material cycles rather than passing all value to customers. This is the difference between a specialty materials business and a commodity converter; it drives margin resilience and valuation quality.

The consumables nature of Avery Dennison’s business and its operating discipline continue to convert accounting earnings into cash that can fund reinvestment, acquisitions, dividends, and repurchases without starving the franchise. Durable cash conversion lets owners benefit even in a low-growth end market; weak conversion would make growth and capital returns less valuable.

Per-share value creation depends on Avery Dennison pairing capital returns with actual operating improvement; buybacks alone cannot offset a stagnant profit pool for long. If EPS growth is mostly financial engineering, owners face multiple compression when repurchase capacity or earnings quality is questioned.

Avery Dennison must keep balance-sheet leverage from becoming the hidden cost of acquisitions and capital returns, because the thesis relies on flexibility through industrial cycles. If liabilities keep rising faster than cash generation, the company loses room to invest through downturns and the equity deserves a lower multiple.

All standing thesis claims
Original report summary

its label-and-identification consumables franchise can keep pricing above input-cost cycles while newer higher-value identification use cases add growth faster than the mature materials base fades.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Avery Dennison

Where the evidence on Avery Dennison disagrees: Mixed on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 2 strengthening, 2 holding and 1 weakening.

Bull case: what the evidence supports

  • Avery Dennison’s customer-specific labeling and converted-materials products remain embedded enough in customer operations that reorder demand normalizes after inventory cycles rather than permanently migrating to substitutes or cheaper competitors.

    sec.gov ↗

  • Avery Dennison’s coatings, adhesives, converting scale, and customer qualification requirements allow it to protect price/cost spread through raw-material cycles rather than passing all value to customers.

    sec.gov ↗

  • The consumables nature of Avery Dennison’s business and its operating discipline continue to convert accounting earnings into cash that can fund reinvestment, acquisitions, dividends, and repurchases without starving the franchise.

    sec.gov ↗

  • Per-share value creation depends on Avery Dennison pairing capital returns with actual operating improvement; buybacks alone cannot offset a stagnant profit pool for long.

    sec.gov ↗

Bear case: what the evidence questions

  • Avery Dennison must keep balance-sheet leverage from becoming the hidden cost of acquisitions and capital returns, because the thesis relies on flexibility through industrial cycles.

    sec.gov ↗

Thesis-Break Engine

What has broken in Avery Dennison’s thesis

Each break OptimistFi flagged on Avery Dennison, dated — with what has historically followed the same kind of break across the market, not a forecast for Avery Dennison.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Director or principal officer change.

    Avery Dennison filed an SEC 8-K on 2026-10-13: Director or principal officer change. It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Avery Dennison filed an SEC 8-K on 2026-10-05: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Other material event.

    Avery Dennison filed an SEC 8-K on 2026-08-19: Other material event. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large consumer-packaged-goods or retail customers redesign packaging workflows around direct printing, linerless formats, or lower-label-content solutions.
  • Raw paper, film, resin, chemical, or freight inflation accelerates faster than Avery Dennison can reprice contracts.
  • Customer destocking or supplier terms reversal causes a sustained working-capital drag.
  • Management prioritizes repurchases while operating income or net income stagnates.
  • Debt-funded acquisitions or repurchases continue while organic growth remains muted.

AVY news

Loading headlines…

Financial statements

AVY income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

AVY: quick answers

When does Avery Dennison (AVY) report earnings next?
Avery Dennison's next results are projected for February 3, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
What is AVY's short interest?
As of October 30, 2026, 2.1M AVY shares were sold short, 2.77% of its shares outstanding, down 6.1% from the count before. At the stock's average daily volume that is 3.1 days to cover. FINRA publishes the count twice a month. AVY short interest history
Have members of Congress traded AVY?
42 trades in AVY have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed AVY trade
Which well-known investors own AVY?
1 of the 37 well-known funds tracked here reported AVY shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios

AVY in well-known investors’ portfolios

1 of 37 funds reported AVY shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.07%$18.2M+972.4%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.